Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 41: Which of the following statements about meta-analysis is FALSE?

A. It is easy to conduct. (Correct Answer)
B. It is an analysis of multiple analyses.
C. Funnel plots and forest plots are used in its interpretation.
D. An 'apple-oranges' effect can be observed in it.

Explanation: ### Explanation **1. Why Option A is the Correct (False) Statement:** Meta-analysis is considered the highest level of evidence in the hierarchy of evidence-based medicine (EBM). Contrary to being "easy," it is a **complex, rigorous, and time-consuming** statistical process. It requires a systematic review of literature, stringent inclusion/exclusion criteria, assessment of study quality (risk of bias), and sophisticated statistical software to pool data. Therefore, the statement that it is "easy to conduct" is incorrect. **2. Analysis of Other Options:** * **Option B (Analysis of multiple analyses):** This is the literal definition of meta-analysis. It uses statistical methods to combine data from multiple independent studies (usually RCTs) to reach a single quantitative conclusion with higher statistical power. * **Option C (Funnel and Forest plots):** These are the hallmark graphical tools of meta-analysis. * **Forest Plot:** Displays the results of individual studies and the pooled estimate (represented by a diamond). * **Funnel Plot:** Used primarily to detect **publication bias**. * **Option D (Apples-and-oranges effect):** This refers to a common criticism/limitation of meta-analysis. It occurs when a researcher pools studies that are too clinically or methodologically diverse (heterogeneous) to be meaningfully combined, leading to invalid conclusions. **3. High-Yield Clinical Pearls for NEET-PG:** * **Hierarchy of Evidence:** Meta-analysis of RCTs > Systematic Review > RCT > Cohort > Case-Control > Case Series > Case Report. * **Heterogeneity:** Measured using the **I² statistic**. High I² (>50-75%) suggests studies are too different to pool. * **Publication Bias:** If the funnel plot is asymmetrical, it suggests publication bias (small negative studies are often not published). * **Fixed vs. Random Effects Model:** Used to pool data depending on the presence of heterogeneity.

Question 42: A 40-year-old male patient, a smoker with a sedentary lifestyle and truncal obesity, is being evaluated for risk factors associated with coronary heart disease. Which of the following is NOT considered a risk factor?

A. High blood pressure
B. Gender
C. Obesity
D. Drinking hard water (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Drinking hard water**. In epidemiology, risk factors for Coronary Heart Disease (CHD) are categorized into non-modifiable and modifiable factors. Interestingly, several ecological studies have shown an **inverse relationship** between water hardness and cardiovascular mortality. This means that drinking **soft water** is actually associated with a higher risk of CHD, while hard water (rich in magnesium and calcium) may have a protective effect. **Analysis of Options:** * **High blood pressure (A):** This is a major modifiable risk factor. Hypertension increases mechanical stress on arterial walls, leading to endothelial dysfunction and atherosclerosis. * **Gender (B):** This is a non-modifiable risk factor. Men are generally at a higher risk for CHD compared to pre-menopausal women, as estrogen provides a protective effect in females. * **Obesity (C):** Specifically truncal (android) obesity, as mentioned in the clinical vignette, is a significant modifiable risk factor. It is closely linked to metabolic syndrome, insulin resistance, and dyslipidemia. **Clinical Pearls for NEET-PG:** * **Modifiable Risk Factors:** Smoking, hypertension, dyslipidemia (High LDL, Low HDL), diabetes, obesity, and sedentary lifestyle. * **Non-modifiable Risk Factors:** Age, Male gender, and Family history of premature CHD. * **The "Rule of Halves" in Hypertension:** Only half of the cases in the community are diagnosed; of those, only half are treated; and of those, only half are adequately controlled. * **Protective Factors:** High-density lipoprotein (HDL) and physical activity are considered "negative" risk factors.

Question 43: What is true about a point source epidemic?

A. Occurs over more than one incubation period
B. Occurs over one incubation period (Correct Answer)
C. The exposure is continuous
D. The epidemic curve falls very slowly

Explanation: ### Explanation In epidemiology, a **Point Source Epidemic** occurs when a group of susceptible individuals is exposed to a common infectious agent or toxin simultaneously or over a very short period. **Why Option B is correct:** In a point source epidemic, because the exposure is instantaneous (e.g., food poisoning at a single wedding dinner), all cases occur within the span of **one incubation period** of the disease. The epidemic curve typically shows a sharp rise and a rapid decline, reflecting the synchronized onset of symptoms among the exposed population. **Analysis of Incorrect Options:** * **Option A:** If an epidemic occurs over more than one incubation period, it suggests a **Propagated Epidemic**, where the disease spreads from person to person (e.g., Measles or Cholera). * **Option C:** If the exposure is **continuous** (e.g., a contaminated well that isn't closed), it is termed a "Common Source, Continuous Exposure" epidemic. The curve in such cases does not have a sharp peak but rather a plateau. * **Option D:** In a point source epidemic, the curve **falls sharply**, not slowly. A slow decline is characteristic of propagated epidemics or continuous source epidemics where the source of infection persists. **High-Yield NEET-PG Pearls:** * **Classic Example:** Bhopal Gas Tragedy (Non-infectious) or Food Poisoning (Infectious). * **Epidemic Curve:** It is typically **unimodal** (single peak) and positively skewed. * **Median Incubation Period:** Can be calculated by identifying the time interval between the known exposure and the peak of the epidemic curve. * **Key Distinction:** Unlike propagated epidemics, point source epidemics show **no secondary waves** because there is no person-to-person transmission.

Question 44: Herd immunity provides protection to whom?

A. Immunized persons
B. Non-immunized persons (Correct Answer)
C. Both immunized and non-immunized persons
D. Neither immunized nor non-immunized persons

Explanation: ### Explanation **Concept Overview:** Herd immunity (also known as community immunity) is the indirect protection from an infectious disease that happens when a large percentage of a population becomes immune, either through vaccination or previous infection. This reduces the overall amount of virus or bacteria able to spread in the whole community. **Why Option B is Correct:** The core principle of herd immunity is the **indirect protection of susceptible individuals.** While immunized individuals are protected by their own immune response, herd immunity specifically refers to the safety net created for **non-immunized persons** (such as those too young to be vaccinated, the immunocompromised, or those with medical contraindications). Because the chain of transmission is broken by the "immune wall" of the majority, the pathogen cannot find enough susceptible hosts to reach the non-immunized individuals. **Analysis of Incorrect Options:** * **Option A:** Immunized persons are protected by their own **active immunity**, not herd immunity. Herd immunity is an epidemiological phenomenon, not a clinical one. * **Option C & D:** These are incorrect because the term "herd immunity" specifically describes the benefit conferred upon the *unprotected* minority by the *protected* majority. **NEET-PG High-Yield Pearls:** 1. **Herd Immunity Threshold (HIT):** The proportion of the population that must be immune to stop the spread. It is calculated as: $HIT = 1 - (1/R_0)$. 2. **Prerequisite:** Herd immunity only applies to diseases that spread from **person to person** (e.g., Measles, Polio). 3. **The Tetanus Exception:** Herd immunity **does not exist for Tetanus** because the infection is acquired from the environment (soil), not from other people. No matter how many people are vaccinated, an unvaccinated person remains at risk. 4. **Eradication:** Achieving high levels of herd immunity is a prerequisite for the global eradication of diseases like Smallpox.

Question 45: For the calculation of incidence, what is used as the denominator?

A. Mid-year population
B. Population at risk (Correct Answer)
C. Total number of cases
D. Total number of deaths

Explanation: ### Explanation **Correct Answer: B. Population at risk** **Concept:** Incidence measures the number of **new cases** of a disease occurring in a defined population during a specific period. The denominator must represent the group of individuals who are capable of developing the disease (i.e., those who do not already have it and are biologically susceptible). This is known as the **Population at Risk**. * **Formula:** (Number of new cases of a disease during a specified period / Total population at risk during the same period) × 1000. **Why other options are incorrect:** * **A. Mid-year population:** This is the standard denominator for **Prevalence** and **Crude Death Rate**. Prevalence includes both old and new cases, representing the total disease burden at a point in time, rather than the rate of new occurrences. * **C. Total number of cases:** This is used as a numerator in various proportions but never as a denominator for incidence. * **D. Total number of deaths:** This is used as the denominator for calculating **Case Fatality Rate** (Total deaths from a disease / Total cases of that disease), which measures the killing power of a disease. **High-Yield Clinical Pearls for NEET-PG:** * **Incidence = Rate:** It indicates the speed of development of a disease. * **Prevalence = Magnitude:** It indicates the total burden of disease (Prevalence = Incidence × Mean Duration). * **Attack Rate:** This is a type of incidence used specifically during **outbreaks/epidemics** (e.g., food poisoning). * **Denominator Rule:** If the question asks for "Person-Time" (e.g., person-years), it is the most accurate denominator for incidence in longitudinal cohort studies.

Question 46: Which of the following is a live vaccine?

A. Tetanus Toxoid (TT)
B. Bacillus Calmette-Guérin (BCG) (Correct Answer)
C. Diphtheria, Pertussis, Tetanus (DPT)
D. Oral Polio Vaccine (OPV)

Explanation: **Explanation:** The correct answer is **Bacillus Calmette-Guérin (BCG)**. Live attenuated vaccines are prepared from live microorganisms that have been weakened (attenuated) in the laboratory so they can replicate and induce an immune response without causing the disease in healthy individuals. BCG is a live attenuated vaccine derived from *Mycobacterium bovis* and is used primarily to prevent severe forms of childhood tuberculosis, such as tubercular meningitis and miliary TB. **Analysis of Options:** * **Tetanus Toxoid (TT):** This is a **toxoid vaccine**. It contains a modified bacterial toxin that has been rendered nontoxic but remains immunogenic. * **Diphtheria, Pertussis, Tetanus (DPT):** This is a **combination vaccine**. It consists of toxoids (Diphtheria and Tetanus) and a killed/inactivated component (whole-cell Pertussis). * **Oral Polio Vaccine (OPV):** While OPV (Sabin) is indeed a live attenuated vaccine, the question asks to identify "a" live vaccine from the list. In many standardized medical exams, if multiple live vaccines are listed, the most "classic" or primary example (like BCG) is often the intended focus, or the question may be framed to identify the bacterial vs. viral nature. *Note: In a strictly technical sense, both B and D are live vaccines; however, BCG is the quintessential bacterial live vaccine.* **High-Yield NEET-PG Pearls:** * **Bacterial Live Vaccines:** Remember the mnemonic **"BTY"** (BCG, Typhoid Oral/Ty21a, Yellow fever is viral but often confused—stick to BCG and Oral Typhoid for bacteria). * **Viral Live Vaccines:** Smallpox, MMR, Varicella, Yellow Fever, Rotavirus, and OPV. * **BCG Administration:** It is given **Intradermally** (left deltoid) using a tuberculin syringe. It is reconstituted only with **Normal Saline** (distilled water causes irritation). * **Contraindication:** Live vaccines are generally contraindicated in **pregnancy** and **immunocompromised** individuals (except HIV-asymptomatic cases for BCG in high-burden areas).

Question 47: What are the target goals for cure rate and diagnosis rate in the Revised National Tuberculosis Control Programme?

A. Cure rate 85% and diagnosis rate 85%
B. Cure rate 85% and diagnosis rate 70% (Correct Answer)
C. Cure rate 80% and diagnosis rate 85%
D. Cure rate 80% and diagnosis rate 80%

Explanation: The Revised National Tuberculosis Control Programme (RNTCP), based on the WHO-recommended DOTS strategy, established specific global targets to ensure effective disease control and prevent the emergence of drug resistance. ### **Explanation of the Correct Answer** The correct targets are a **Cure Rate of at least 85%** and a **Case Detection Rate (Diagnosis Rate) of at least 70%**. * **Cure Rate (85%):** This high threshold is necessary to ensure that the majority of infectious patients become non-infectious, thereby breaking the chain of transmission and preventing the development of Multi-Drug Resistant TB (MDR-TB). * **Diagnosis Rate (70%):** The goal is to identify at least 70% of the estimated new sputum smear-positive cases in the community. Detecting the majority of "open" cases ensures that the primary sources of infection are brought under medical supervision. ### **Analysis of Incorrect Options** * **Options A & C:** A diagnosis rate of 85% was considered overly ambitious for the initial phases of RNTCP given the infrastructure and health-seeking behavior in India at the time. * **Option D:** An 80% cure rate is insufficient for effective epidemiological control; mathematical modeling suggests that an 85% cure rate is the "tipping point" required to significantly reduce the prevalence of the disease. ### **High-Yield Clinical Pearls for NEET-PG** * **Evolution of Targets:** Under the current **National TB Elimination Program (NTEP)**, the vision has shifted from "control" to "elimination" (defined as <1 case per million population) by **2025**, five years ahead of the global Sustainable Development Goals (SDG) target of 2030. * **Key Indicator:** The most important indicator for the success of RNTCP/NTEP is the **Sputum Conversion Rate** at the end of the intensive phase. * **NSP (New Sputum Positive):** These cases are the primary focus of the 70/85 targets because they are the most infectious.

Question 48: Which of the following statements about the late expanding phase of the demographic cycle is TRUE?

A. Birth rate is lower than the death rate
B. High death rate and high birth rate
C. Death rate declines more than the birth rate (Correct Answer)
D. Death rate declines while the birth rate remains unchanged

Explanation: ### Explanation The **Demographic Cycle** describes the historical shift in birth and death rates as a country progresses through stages of economic development. **1. Why the Correct Answer is Right:** In the **Late Expanding Phase (Stage 3)**, the death rate continues to decline, but the birth rate also begins to fall significantly. However, the **death rate declines more rapidly or remains lower than the birth rate**, leading to a continued, albeit slowing, increase in the total population. This stage is characterized by increased urbanization, access to contraception, and improved female literacy. **2. Analysis of Incorrect Options:** * **Option A (Birth rate lower than death rate):** This describes the **Declining Phase (Stage 5)**. Here, the population actually decreases (e.g., Germany, Hungary). * **Option B (High death rate and high birth rate):** This describes the **High Stationary Phase (Stage 1)**. The population remains stable because the high number of births is offset by high mortality. * **Option D (Death rate declines while birth rate remains unchanged):** This describes the **Early Expanding Phase (Stage 2)**. This is the "Population Explosion" stage where medical advancements reduce mortality, but social norms keep fertility high (e.g., many African countries). **3. High-Yield Facts for NEET-PG:** * **India’s Status:** India is currently in the **Late Expanding Phase (Stage 3)**. * **Low Stationary (Stage 4):** Characterized by low birth and low death rates (e.g., USA, UK). * **Demographic Gap:** The difference between the birth rate and death rate. It is widest during the transition from Stage 2 to Stage 3. * **Key Driver of Stage 3:** The shift from Stage 2 to Stage 3 is primarily driven by a **decline in fertility** due to family planning and socio-economic changes.

Question 49: What is the ratio of incidence among exposed and non-exposed individuals called?

A. Risk ratio (Correct Answer)
B. Odds ratio
C. Attributable risk
D. Standardized incidence ratio

Explanation: ### Explanation **Correct Answer: A. Risk Ratio** **Why it is correct:** The **Risk Ratio (RR)**, also known as **Relative Risk**, is the ratio of the incidence of a disease among individuals exposed to a specific risk factor compared to the incidence among those not exposed. It measures the strength of the association between an exposure and an outcome. * **Formula:** $RR = \frac{\text{Incidence among exposed } (I_e)}{\text{Incidence among non-exposed } (I_o)}$ * It is the primary measure of association derived from **Cohort Studies**. **Why other options are incorrect:** * **B. Odds Ratio (OR):** This is the ratio of the odds of exposure in cases to the odds of exposure in controls. It is used primarily in **Case-Control Studies** because incidence cannot be directly calculated in such designs. * **C. Attributable Risk (AR):** This is the **difference** (not the ratio) between the incidence in the exposed and non-exposed groups ($I_e - I_o$). It indicates how much of the disease burden can be eliminated if the exposure is removed. * **D. Standardized Incidence Ratio (SIR):** This is the ratio of the observed number of cases in a study population to the number of cases expected if the study population had the same incidence rate as a standard/reference population. **NEET-PG High-Yield Pearls:** 1. **RR = 1:** No association between exposure and disease. 2. **RR > 1:** Positive association (exposure is a risk factor). 3. **RR < 1:** Negative association (exposure is protective, e.g., vaccines). 4. **Incidence** can only be calculated in **Prospective studies** (Cohort). 5. If a disease is rare, the **Odds Ratio** becomes a good approximation of the **Relative Risk**.

Question 50: Blanket or mass treatment is indicated in all of the following conditions EXCEPT:

A. Trachoma
B. Malaria
C. Yaws
D. Dengue fever (Correct Answer)

Explanation: **Explanation:** The concept of **Mass Treatment** (or Blanket Treatment) involves treating every individual in a defined community, regardless of whether they show symptoms, to eliminate the reservoir of infection. This strategy is typically employed for diseases that are highly contagious, have a high prevalence, or lack an effective vaccine. **Why Dengue Fever is the correct answer:** Dengue is a viral disease transmitted by the *Aedes aegypti* mosquito. There is **no specific antiviral treatment** for Dengue; management is purely supportive (fluid resuscitation and monitoring). Furthermore, treating an asymptomatic human does not prevent the spread, as the primary control strategy relies on **vector control** (source reduction and insecticides) rather than mass chemotherapy. **Analysis of Incorrect Options:** * **Trachoma:** Mass antibiotic distribution (Azithromycin) is a core component of the WHO **SAFE** strategy when the prevalence of active trachoma in children is >5%. * **Malaria:** Mass Drug Administration (MDA) is indicated in specific scenarios, such as during epidemics, in complex emergencies, or for the elimination of *P. falciparum* in isolated areas to rapidly reduce the parasite reservoir. * **Yaws:** Under the **Morgues Strategy**, mass treatment with a single dose of Azithromycin is the standard protocol for eradication in endemic communities. **High-Yield Clinical Pearls for NEET-PG:** * **Mass Treatment vs. Selective Treatment:** Mass treatment is for the whole community; selective treatment targets only those with positive diagnostic tests. * **Other diseases requiring Mass Treatment:** Lymphatic Filariasis (DEC + Albendazole), Onchocerciasis (Ivermectin), and Schistosomiasis (Praziquantel). * **Total Mass Treatment (TMT):** In Yaws, if the prevalence is >5%, the entire community is treated. If <5%, "Juvenile Mass Treatment" (treating all children <15 years) is performed.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free